Results 31 to 40 of about 6,963,646 (317)
Cardiotoxicity and Cancer Therapy [PDF]
Angiology, 2013 A fundamental concept of treatment is to do no harm. However, with cancer treatment this is not always possible. Chemotherapy is associated with cardiovascular (CV) complications.1,2 This risk is even greater in the elderly patients and patients with established CV disease.
Vasiliadis, I +2 more
openaire +3 more sources
OncoImmunology, 2021 Cells in the tumor microenvironment of Follicular lymphoma (FL) express checkpoint molecules such as programmed death ligands 1 and 2 (PD-L1 and PD-L2) and are suppressing anti-tumor immune activity.
Uffe Klausen +18 more
doaj +1 more source
Node-positive breast cancer: Which are the best chemotherapy regimens? [PDF]
, 2008 Breast cancer-associated mortality has been significantly reduced since the 1990s, mainly because of early diagnosis and systemic therapeutic interventions.
Bauerfeind, Ingo +6 more
core +1 more source
, 2021 Oligometastatic cancer is characterized by a limited number of metastatic deposits. Compared with lung cancer patients who have more widespread disease, oligometastatic lung cancer patients have more favorable survival outcomes.
David L. Billing, Andreas Rimner
core +1 more source
Impact of heterogeneities on lateral penumbra in uniform scanning proton therapy [PDF]
, 2013 Purpose: In the treatment planning of uniform scanning proton therapy, an aperture block is designed for each beam with a margin, which typically includes the lateral penumbra measured in water (homogenous) medium.
Rana, Suresh; Department of Medical Physics, ProCure Proton Therapy Center, Oklahoma City +1 more
core +1 more source
Intensity modulated radiotherapy versus volumetric modulated arc therapy in breast cancer: A comparative dosimetric analysis [PDF]
, 2015 Purpose: Intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) has the capacity to optimize the dose distribution. We analyzed the dosimetric differences of plans in treatment planning system (TPS) between VMAT and IMRT in ...
Soubhagya, Bhudevi; Basavataram Indo-American Cancer Institute and Research center, Hyderabad +2 more
core +1 more source
Neutrophil Extracellular Traps in Cancer Therapy Resistance
, 2022 Neutrophils and their products are increasingly recognized to have a key influence on cancer progression and response to therapy. Their involvement has been shown in nearly every aspect of cancer pathophysiology with growing evidence now supporting their
Jonathan J. Cools-Lartigue +7 more
core +1 more source
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Scientific Reports, 2023 Ewing sarcoma (EWS) is a malignant tumor arising in bone or soft tissue that occurs in adolescent and young adult patients as well as adults later in life.
Jin-Ah Kim +11 more
doaj +1 more source
Molecular Oncology, 2020 Hydrophobic neoantigens are more immunogenic because they are better presented by the major histocompatibility complex and better recognized by T cells. Tumor cells can evade the immune response by expressing checkpoints such as programmed death ligand 1.
Timothy V. Pham +6 more
doaj +1 more source
Technical Innovations & Patient Support in Radiation Oncology, 2020 Fifteen years of reported incidents were reviewed to provide insight into the effectiveness of an Incident Learning System (ISL). The actual error rate over the 15 years was 1.3 reported errors per 1000 treatment attendances.
Sandie Smith +8 more
doaj +1 more source